Observation of combination of lamivudine and interferon in the treatment of patients with chronic hepatitis B
Yongping Wang
Abstract
Yongping Wang
Abstract
Objective To observe the effect of combination of lamivudine and interferon in the treatment of patients with chronic hepatitis B.Methods 150 patients with chronic hepatitis B were divided into 3 groups,each group had 50 patients.The patients in combination group received lamivudine and interferonα-2b therapy for one year,the patients in lamivudine group and interferon group received lamivudine and interferonα-2b therapy respectively for one year.Results After one year,the HBV DNA loss and HBeAg/anti-HBe seroconversion in combination group were 86% and 48% respectively,they were higher than in lamivudine group and interferon group(P0.05),YMDD mutations were detected in 1 patients in combination group(2%) but 8 patients in lamivudine group(16%).Conclusion Combination of lamivudine and interferon in the treatment of patients with chronic hepatitis B get a better effect and decrease YMDD mutation.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To observe the effect of combination of lamivudine and interferon in the treatment of patients with chronic hepatitis B.Methods 150 patients with chronic hepatitis B were divided into 3 groups,each group had 50 patients.The patients in combination group received lamivudine and interferonα-2b therapy for one year,the patients in lamivudine group and interferon group received lamivudine and interferonα-2b therapy respectively for one year.Results After one year,the HBV DNA loss and HBeAg/anti-HBe seroconversion in combination group were 86% and 48% respectively,they were higher than in lamivudine group and interferon group(P0.05),YMDD mutations were detected in 1 patients in combination group(2%) but 8 patients in lamivudine group(16%).Conclusion Combination of lamivudine and interferon in the treatment of patients with chronic hepatitis B get a better effect and decrease YMDD mutation.
Key concepts: Lamivudine, Medicine, Interferon, HBeAg, Chronic hepatitis, Seroconversion, Gastroenterology, Combination therapy